Literature DB >> 10369255

A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria.

J C Knight1, I Udalova, A V Hill, B M Greenwood, N Peshu, K Marsh, D Kwiatkowski.   

Abstract

Genetic variation in cytokine promoter regions is postulated to influence susceptibility to infection, but the molecular mechanisms by which such polymorphisms might affect gene regulation are unknown. Through systematic DNA footprinting of the TNF (encoding tumour necrosis factor, TNF) promoter region, we have identified a single nucleotide polymorphism (SNP) that causes the helix-turn-helix transcription factor OCT-1 to bind to a novel region of complex protein-DNA interactions and alters gene expression in human monocytes. The OCT-1-binding genotype, found in approximately 5% of Africans, is associated with fourfold increased susceptibility to cerebral malaria in large case-control studies of West African and East African populations, after correction for other known TNF polymorphisms and linked HLA alleles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369255     DOI: 10.1038/9649

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  95 in total

Review 1.  Science, medicine, and the future: susceptibility to infection.

Authors:  D Kwiatkowski
Journal:  BMJ       Date:  2000-10-28

2.  SELEX_DB: a database on in vitro selected oligomers adapted for recognizing natural sites and for analyzing both SNPs and site-directed mutagenesis data.

Authors:  Julia V Ponomarenko; Galina V Orlova; Anatoly S Frolov; Mikhail S Gelfand; Mikhail P Ponomarenko
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

3.  Identification and characterization of the potential promoter regions of 1031 kinds of human genes.

Authors:  Y Suzuki; T Tsunoda; J Sese; H Taira; J Mizushima-Sugano; H Hata; T Ota; T Isogai; T Tanaka; Y Nakamura; A Suyama; Y Sakaki; S Morishita; K Okubo; S Sugano
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

Review 4.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 5.  Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

Authors:  Magdalena Plebanski; Owen Proudfoot; Dodie Pouniotis; Ross L Coppel; Vasso Apostolopoulos; Graham Flannery
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  rSNP_Guide, a database system for analysis of transcription factor binding to DNA with variations: application to genome annotation.

Authors:  Julia V Ponomarenko; Tatyana I Merkulova; Galina V Orlova; Oleg N Fokin; Elena V Gorshkova; Anatoly S Frolov; Vadim P Valuev; Mikhail P Ponomarenko
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

Review 7.  Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.

Authors:  Norman H Lee
Journal:  Anticancer Agents Med Chem       Date:  2010-10-01       Impact factor: 2.505

8.  Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis.

Authors:  Masao Ota; Yoshihiko Katsuyama; Hideaki Hamano; Takeji Umemura; Akinori Kimura; Kaname Yoshizawa; Kendo Kiyosawa; Hirofumi Fukushima; Seiamak Bahram; Hidetoshi Inoko; Shigeyuki Kawa
Journal:  Immunogenetics       Date:  2006-11-21       Impact factor: 2.846

9.  Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China.

Authors:  Ruiwen Chen; Meng Fang; Qing Cai; Shiwei Duan; Ke Lv; Ning Cheng; Daming Ren; Jie Shen; Dongyi He; Lin He; Shuhan Sun
Journal:  Rheumatol Int       Date:  2007-08-21       Impact factor: 2.631

10.  Modulation of cystic fibrosis lung disease by variants in interleukin-8.

Authors:  A D Hillian; D Londono; J M Dunn; K A B Goddard; R G Pace; M R Knowles; M L Drumm
Journal:  Genes Immun       Date:  2008-06-19       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.